Investor Presentaiton slide image

Investor Presentaiton

GROSS MARGIN PERFORMANCE Gross Margin Year-over-Year Change By Reported Segment Consolidated Gross Margin 50% 40% 30% 20% 10% 0% Canadian Cannabis Gross Margin 50% 40% 34% 36% 30% 20% 10% 0% -1% -10% -10% -20% -20% -15% Q2 FY23 Q2 FY24 Q2 FY23 Q2 FY24 Rest-of-World Cannabis Gross Margin Storz & Bickel Gross Margin 50% 40% 30% 20% 10% 50% 44% 40% 30% 30% 20% 10% 33% 0% 0% -10% -10% -13% -20% -20% Q2 FY23 Q2 FY24 Q2 FY23 Q2 FY24 Drivers of Q2 FY2024 Consolidated Gross Margin Performance (+) Improvement in our Canada cannabis segment, primarily attributable to: (i) the realized benefit of our cost savings program and strategic changes to our business; (ii) a year-over-year decrease in write- downs of excess inventory; and (iii) opportunistic utilization of lower cost inputs (+) Year-over-year decrease in restructuring charges, (+) Improvement in our Rest-of-world cannabis and This Works segments, primarily due to lower excess and obsolete inventory charges in the second quarter of fiscal 2024. 18
View entire presentation